2
|
Mital R, Lovegrove MC, Moro RN, Geller AI, Weidle NJ, Lind JN, Budnitz DS. US emergency department visits for acute harms from over-the-counter cough and cold medications, 2017-2019. Pharmacoepidemiol Drug Saf 2022; 31:225-234. [PMID: 34757641 PMCID: PMC10917081 DOI: 10.1002/pds.5384] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 10/06/2021] [Accepted: 11/05/2021] [Indexed: 11/08/2022]
Abstract
BACKGROUND AND PURPOSE Characterization of emergency department (ED) visits for acute harms related to use of over-the-counter cough and cold medications (CCMs) by patient demographics, intent of CCM use, concurrent substance use, and clinical manifestations can help guide prevention of medication harms. METHODS Public health surveillance data from the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project were used to estimate numbers and population rates of ED visits from 2017 to 2019. RESULTS Based on 1396 surveillance cases, there were an estimated 26 735 (95% CI, 21 679-31 791) US ED visits for CCM-related harms annually, accounting for 1.3% (95% CI, 1.2-1.5%) of all ED visits for medication adverse events. Three fifths (61.4%, 95% CI, 55.6-67.2%) of these visits were attributed to non-therapeutic CCM use (nonmedical use, self-harm, unsupervised pediatric exposures). Most visits by children aged <4 years (74.0%, 95% CI, 59.7-88.3%) were for unsupervised CCM exposures. Proportion hospitalized was higher for visits for self-harm (76.5%, 95% CI, 68.9-84.2%) than for visits for nonmedical use (30.3%, 95% CI, 21.1-39.6%) and therapeutic use (8.8%, 95% CI, 5.9-11.8%). Overall, estimated population rates of ED visits for CCM-related harms were higher for patients aged 12-34 years (16.5 per 100 000, 95% CI, 13.0-20.0) compared with patients aged <12 years (5.1 per 100 000, 95% CI, 3.6-6.5) and ≥ 35 years (4.3 per 100 000, 95% CI, 3.4-5.1). Concurrent use of other medications, illicit drugs, or alcohol was frequent in ED visits for nonmedical use (61.3%) and self-harm (75.9%). CONCLUSIONS Continued national surveillance of CCM-related harms can assess progress toward safer use.
Collapse
Affiliation(s)
- Rohan Mital
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
- College of Medicine, The Ohio State University, Columbus, Ohio, USA
| | - Maribeth C Lovegrove
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
| | - Ruth N Moro
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
| | - Andrew I Geller
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
| | - Nina J Weidle
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
- Eagle Global Scientific, LLC (contractor to CDC), Atlanta, Georgia, USA
| | - Jennifer N Lind
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
| | - Daniel S Budnitz
- Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
| |
Collapse
|
3
|
Foo RMC, Hoff C, Sekhri NK, Weber G. Attitudes toward and Barriers to Acetaminophen Use in the Chronic Pain Population: A Cross-Sectional Study. J Pain Palliat Care Pharmacother 2020; 34:107-113. [DOI: 10.1080/15360288.2020.1734139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
Affiliation(s)
- R. Marcus C. Foo
- R. Marcus C. Foo, MS, is with the New York Medical College, Valhalla, New York, USA. Chantal Hoff, MPH, is Children's Health Fund, New York, New York, USA. Nitin K. Sekhri, MD, is with the Department of Anesthesiology, New York Medical College, Valhalla, New York, USA. Garret Weber, MD, is with the Department of Anesthesiology, New York Medical College, Valhalla, New York, USA
| | - Chantal Hoff
- R. Marcus C. Foo, MS, is with the New York Medical College, Valhalla, New York, USA. Chantal Hoff, MPH, is Children's Health Fund, New York, New York, USA. Nitin K. Sekhri, MD, is with the Department of Anesthesiology, New York Medical College, Valhalla, New York, USA. Garret Weber, MD, is with the Department of Anesthesiology, New York Medical College, Valhalla, New York, USA
| | - Nitin K. Sekhri
- R. Marcus C. Foo, MS, is with the New York Medical College, Valhalla, New York, USA. Chantal Hoff, MPH, is Children's Health Fund, New York, New York, USA. Nitin K. Sekhri, MD, is with the Department of Anesthesiology, New York Medical College, Valhalla, New York, USA. Garret Weber, MD, is with the Department of Anesthesiology, New York Medical College, Valhalla, New York, USA
| | - Garret Weber
- R. Marcus C. Foo, MS, is with the New York Medical College, Valhalla, New York, USA. Chantal Hoff, MPH, is Children's Health Fund, New York, New York, USA. Nitin K. Sekhri, MD, is with the Department of Anesthesiology, New York Medical College, Valhalla, New York, USA. Garret Weber, MD, is with the Department of Anesthesiology, New York Medical College, Valhalla, New York, USA
| |
Collapse
|